Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.
Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.
Gastric cancer (GC) remains a major global health issue with high incidence and mortality. This study evaluates the global burden and health disparities of GC from 1990 to 2021 and projects trends through 2036, providing evidence for targeted control measures. The data were sourced from the 2021 Global Burden of Diseas...
Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality worldwide, and analyzing its most recent disease trends is essential for effective prevention and control strategies. Data on the global burden of EC were obtained from the 2021 Global Burden of Disease study, including prevalence, incidence,...
Yi-Fan Li, Guo-Peng Jiang, Xia Liu et al.· Medicine· 0 citations
Decomposition analysis indicated that population aging and population growth were the primary drivers of increasing DALYs, partially offset by reductions in age-specific rates, which indicated improved survival and disease management despite rising case numbers.
Jing Wang, Lei Zhang, Yanjun Wang et al.· Medicine· 0 citations
Bayesian age-period-cohort projections indicate that by 2035, GC incidence is anticipated to reach 1,159,745, while the expected numbers of deaths and DALYs are forecasted to decline to 667,145 and 15,783,072, respectively, while the impact of GC in older age demographics is projected to increase significantly.
Liying Ma, Juan Ou, Zi-Jun Qiu et al.· Medicine· 0 citations
Pancreatic cancer burden in the EU has increased substantially and is projected to continue rising through 2050, emphasizing the need for age-adapted and equitable cancer control strategies.
Yibo Cui, Guoping Yang, Gang Wang· Cancer Treatment and Researc...· 0 citations
An emerging structural divergence is revealed in China's cancer burden, with incidence increasingly concentrated in women and mortality in men, and the need for sex- and age-specific cancer control strategies is highlighted.
Dan Wang, Zhen-Zhen Rao, Wei Xiong et al.· Science China Life Sciences· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.